This company develops advanced bioluminescent technologies for various applications. They focus on engineering novel light-emitting systems derived from biological sources. Their work aims to provide sustainable and high-efficiency illumination solutions.

Bridgefy provides a messaging app that utilizes Bluetooth Low-Energy technology to enable communication without Internet access, creating a mesh network among users within a 330-foot range. This solution is particularly valuable during natural disasters, large events, or in areas with limited connectivity, ensuring reliable messaging when traditional communication methods fail.

Calla Lily Clinical Care develops advanced drug delivery systems specifically for gynecological applications. Their patented Callavid® platform technology addresses current limitations in vaginal drug administration by offering a leak-free solution. This innovation aims to improve patient adherence and confidence across fertility, pregnancy support, and other women's health conditions.

Gladys connects families with verified local caregivers and helpers to provide personalized in-home support for older adults, addressing the challenge of finding reliable care. By eliminating agency overheads, Gladys ensures competitive pricing while enhancing the quality of care through a community-driven model that fosters trust and respect.

Impli has developed a biosensing platform that utilizes subdermal sensors and NFC technology to provide real-time monitoring of hormone levels critical for in vitro fertilization (IVF). This technology reduces the need for frequent blood draws, enabling fertility specialists to optimize treatment protocols and improve the chances of successful pregnancies.

Laka is a peer-to-peer bicycle insurance platform that calculates monthly contributions based on collective claims, eliminating fixed premiums and excess fees. It provides coverage for theft, accidental damage, and third-party liability, ensuring cyclists receive prompt support and replacement without depreciation on claims.

OSSTEC develops orthopedic implants utilizing biomimetic 3D printing technology for cementless fixation in joint replacement surgery. Their technology focuses on enhancing implant fixation to improve long-term outcomes and reduce loosening risks associated with current implants. This approach aims to simplify knee replacement procedures and support more active patient lifestyles.

The startup develops an air purification system that utilizes proprietary filtration technology to capture particulate matter and harmful gases in indoor environments. This system aims to enhance urban air quality, creating healthier and safer spaces for residents by effectively removing pollutants.

Thermulon has developed a proprietary chemical process for the rapid and scalable production of aerogel insulation materials, which are significantly more effective than traditional insulation options. This technology addresses the challenges of high manufacturing costs and slow production times, enabling industries such as construction and aerospace to utilize lightweight, high-performance thermal insulation.